المؤلفون: Minyoung Youn, Stephanie M. Smith, Alex Gia Lee, Hee-Don Chae, Elizabeth Spiteri, Jason Erdmann, Ilana Galperin, Lara Murphy Jones, Michele Donato, Parveen Abidi, Henrique Bittencourt, Norman Lacayo, Gary Dahl, Catherine Aftandilian, Kara L. Davis, Jairo A. Matthews, Steven M. Kornblau, Min Huang, Nathan Sumarsono, Michele S. Redell, Cecilia H. Fu, I-Ming Chen, Todd A. Alonzo, Elizabeth Eklund, Jason Gotlib, Purvesh Khatri, E. Alejandro Sweet-Cordero, Nobuko Hijiya, Kathleen M. Sakamoto

المصدر: Cancers, Vol 13, Iss 24, p 6263 (2021)

مصطلحات موضوعية: pediatric CML, CML CD34+ cells, RNA sequencing, transcriptome, Rho pathway, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2072-6694/13/24/6263; https://doaj.org/toc/2072-6694

URL الوصول: https://doaj.org/article/f980bf46519943db8aa0897511475f79

المؤلفون: Joseph L. Wiemels, Catherine Metayer, Xiaomei Ma, Margaret R. Wrensch, Robert B. Jenkins, John K. Wiencke, Jeanette E. Eckel-Passow, Daniel H. Lachance, Lucie S. McCoy, Cecilia H. Fu, Terri Rice, Jianqiao Xiao, Alyson A. Endicott, Semira Gonseth, Ivan V. Smirnov, Helen M. Hansen, Adam J. de Smith, Kyle M. Walsh

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab483bb14f52ee590567886bfa40b3c
https://doi.org/10.1158/0008-5472.22410779.v1

المؤلفون: Joseph L. Wiemels, Catherine Metayer, Xiaomei Ma, Margaret R. Wrensch, Robert B. Jenkins, John K. Wiencke, Jeanette E. Eckel-Passow, Daniel H. Lachance, Lucie S. McCoy, Cecilia H. Fu, Terri Rice, Jianqiao Xiao, Alyson A. Endicott, Semira Gonseth, Ivan V. Smirnov, Helen M. Hansen, Adam J. de Smith, Kyle M. Walsh

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044d859117d7d1a6a5e73e258aab2d8e
https://doi.org/10.1158/0008-5472.c.6508067.v1

المؤلفون: Cecilia H Fu, Kathleen M Sakamoto

المصدر: Expert Opinion on Pharmacotherapy. 8:1977-1984

مصطلحات موضوعية: Adult, Pharmacology, Antineoplastic Agents, General Medicine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Injections, Intramuscular, Polyethylene Glycols, Injections, Intravenous, Asparaginase, Humans, Pharmacology (medical), Controlled Clinical Trials as Topic, Child, Drug Approval

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe6a46a933958bb68a43af14168ab28
https://doi.org/10.1517/14656566.8.12.1977

المؤلفون: Kenneth I. Weinberg, Vassilios I. Avramis, Sagrario Martin-Aragon, Cecilia H. Fu, Peter V. Danenberg, Veronica C. Ardi

المصدر: Cancer chemotherapy and pharmacology. 48(2)

مصطلحات موضوعية: Cancer Research, Asparaginase, Myeloid, Leukemia, T-Cell, HL60, Apoptosis, HL-60 Cells, Biology, Toxicology, Tioguanine, Polyethylene Glycols, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, medicine, Tumor Cells, Cultured, Humans, Pharmacology (medical), Cytotoxicity, Thioguanine, Pharmacology, Leukemia, Cytarabine, Drug Synergism, U937 Cells, medicine.disease, Fludarabine, Leukemia, Lymphoid, medicine.anatomical_structure, Oncology, chemistry, Biochemistry, Proto-Oncogene Proteins c-bcl-2, Drug Resistance, Neoplasm, Leukemia, Myeloid, Cancer research, Drug Screening Assays, Antitumor, Tumor Suppressor Protein p53, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37da9a478ccad7b0ec3fdba330828595
https://pubmed.ncbi.nlm.nih.gov/11561778

المؤلفون: Kutny MA; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Alonzo TA; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Gerbing RB; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Wang YC; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Raimondi SC; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Hirsch BA; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Fu CH; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Meshinchi S; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Gamis AS; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Feusner JH; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ., Gregory JJ Jr; Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Sep 10; Vol. 35 (26), pp. 3021-3029. Date of Electronic Publication: 2017 Aug 02.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Anthracyclines/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Arsenicals/*administration & dosage , Leukemia, Promyelocytic, Acute/*drug therapy , Oxides/*administration & dosage, Adolescent ; Adult ; Arsenic Trioxide ; Child ; Child, Preschool ; Consolidation Chemotherapy ; Cytarabine/administration & dosage ; Disease-Free Survival ; Female ; Historically Controlled Study ; Humans ; Male ; Mercaptopurine/administration & dosage ; Methotrexate/administration & dosage ; Young Adult